Life Sciences Tools and Services
Company Overview of Ajinomoto Althea, Inc.
Ajinomoto Althea, Inc. provides biopharmaceutical contract development and manufacturing services to biotechnology and pharmaceutical companies worldwide. It offers development services in the areas of process development, protein formulation technology, analytical development and validation, and regulatory support. The company also provides services related to drug substances, such as cGMP protein/plasmid DNA production, microbial cell banking, patented protein expression technology, analytics, and regulatory support. In addition, it offers drug product manufacturing services, including formulation, aseptic vial filling, aseptic pre-filled syringe filling, lyophilization, stability and rele...
11040 Roselle Street
San Diego, CA 92121
Founded in 1997
Key Executives for Ajinomoto Althea, Inc.
Chief Executive Officer and President
Chief Financial Officer and Senior Vice President
Senior Vice President of Operations
Vice President of Biologics
Compensation as of Fiscal Year 2016.
Ajinomoto Althea, Inc. Key Developments
Ajinomoto Althea, Inc. Expands its Capacity of Fill Finish Manufacturing with Addition of Second Shift
Mar 15 16
Ajinomoto Althea, Inc. announced it is expanding the capacity of its Fill and Finish operations through the addition of a second manufacturing shift. Althea's contract manufacturing business has experienced exceptionally strong growth driven by biotech companies outsourcing to Althea sterile fill and finish parenteral manufacturing to support their clinical and commercial drug programs. Althea's second shift will come on-line in early June, increasing the number of manufacturing slots for commercial and clinical drug programs, thereby significantly reducing lead times from project kickoff to fill date. To support this significant increase in its parenteral manufacturing capacity, Althea has invested in additional operational capabilities, more visual inspection suites, automated quality systems, and project management expansion.
Ajinomoto Althea, Inc. Expands Manufacturing Capabilities to Antibody Drug Conjugate Fill Finish and Bioconjugation
Oct 14 15
Ajinomoto Althea, Inc. announced it is expanding its existing biological drug product manufacturing operations to include highly active materials such as Antibody Drug Conjugates (ADCs). The new facility is located in close proximity to existing Althea operations in San Diego, CA.
Ajinomoto Althea, Inc. Presents at 7th annual Biotech Showcase Conference 2015, Jan-12-2015
Dec 24 14
Ajinomoto Althea, Inc. Presents at 7th annual Biotech Showcase Conference 2015, Jan-12-2015 . Venue: Parc 55 Wyndham San, Francisco - Union Square, San Francisco, CA 94102, United States.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|